THUMPD3 and lung carcinoma: We provide evidence for a novel mechanism in which THUMPD3 affects the alternative splicing of cancer relevant and ECM enriched mRNAs, such as Fibronectin-1 mRNA, thereby promoting a molecular environment permissive to lung cancer progression.